Patent Assignment
Reel/Frame 029198/0345
Change of Name
Recorded: 2012-10-25
Pages: 5
Assignor
AMYLIN PHARMACEUTICALS, INC.
Executed: 2012-08-08
Assignee
AMYLIN PHARMACEUTICALS, LLC
9360 TOWNE CENTRE DRIVE, ATTN: INTELLECTUAL PROPERTY GROUP, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(20)
Pharmaceutical Compositions Containing Exendins
Exendins and Exendin Agonists for Weight Reduction and Obesity
Exendin Pharmaceutical Compositions
Metabolic Intervention with Glp-1 or Its Biologically Active Analogues to Improve the Function of the Ischemic and Reperfused Brain
Patent:
41,288 →
Application:
10/913,309 →
Pancreatic polypeptide family motifs and polypeptides comprising the same
Hybrid Polypeptides Having Glucose Lowering Activity
Exendin Analog Formulations
Treatment of Gestational Diabetes
Pancreatic Polypeptide Family Motifs, Polypeptides and Methods Comprising the Same
Transmucosal delivery of peptides and proteins
Application:
11/628,123 →
Publication:
US 2009/0069226
Amylin Family Polypeptide-6 (Afp-6) Analogs and Methods of Making and Using Them
Methods for treating obesity and obesity related diseases and disorders
Application:
11/665,675 →
Publication:
US 2009/0156474
Gip Analog and Hybrid Polypeptides with Selectable Properties
Use of Glp-1 and Agonists Thereof to Prevent Cardiac Myocyte Apoptosis
Application:
11/857,951 →
Publication:
US 2009/0264352
Amylin Agonist for Treating Depression, Anxiety Disorder and Schizophrenia
Methods of Controlling Binge Eating Disorders
Pharmaceutical Formulations Comprising Incretin mimetic Peptide and Aprotic Polar Solvent
Application:
11/910,723 →
Publication:
US 2008/0200383
Use of Exendin and Analogs Thereof To Delay or Prevent Cardiac Remodeling
Methods of Treating Obesity with two Different Anti-Obesity Agents
Hybrid Polypeptides with Selectable Properties
Application:
12/063,420 →
Publication:
US 2009/0286723
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Oct 1, 2012
From: ELI LILLY AND COMPANY
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 029057/0342 →
Release of Security Interest
Oct 2, 2012
From: ELI LILLY AND COMPANY
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 029062/0639 →
Amylin Pharmaceuticals, Llc Assigns an Equal and Undivided One-Half of Its Entire Right, Title and Interest to Astrazeneca Pharmaceuticals Lp
Oct 26, 2012
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 029195/0555 →